News | July 12, 2025
Indegene launches NEXT Medical Writing Automation
To streamline complex medical writing workflows with GenAI
To streamline complex medical writing workflows with GenAI
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Globally, BRUKINSA is approved in more than 70 countries
Subscribe To Our Newsletter & Stay Updated
